Article
Omentin Val109Asp polymorphism and risk of coronary artery disease.
Asian cardiovascular & thoracic annals - 1 Mar 2017
Jamshidi Javad, Ghanbari Mehrdad, Asnaashari Ali, Jafari Nosaybeh, Valizadeh Gholam Abbas
Abstract excerpt
Background Omentin is an adipocytokine with antiinflammatory properties. It has been reported to be involved in atherosclerosis and coronary artery disease. We aimed to investigate the association of omentin Val109Asp polymorphism with coronary artery disease in an Iranian population. Methods For a case-control study, 400 individuals were recruited: 200 with coronary artery disease and 200 healthy controls....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
